Clinical Trial

A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy

Name: A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy — clinical trial record (NCT07021963)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study mainly evaluates the long-term safety of HRS-1893 in subjects with hypertrophic cardiomyopathy.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-06-06.

Status change: Not Yet Recruiting → Recruiting 2025-09-08

Trial Details

NCT Number	NCT07021963
Lead Sponsor	Shandong Suncadia Medicine Co., Ltd.
Conditions	Hypertrophic Cardiomyopathy
Enrollment	300 participants
Start Date	2025-07-04
Primary Completion	2027-12 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2025-09-10